Frankfurt - Delayed Quote EUR
Denali Therapeutics Inc. (4DN.F)
12.88
+1.51
+(13.24%)
As of 8:18:00 AM GMT+2. Market Open.
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 13.88M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| KROGNES STEVE E Director | Sale at price 20.81 per share. | Direct | 69,485 | Jan 7, 2025 |
| WATTS RYAN J Chief Executive Officer | Sale at price 20.22 - 20.81 per share. | Direct | 750,955 | Jan 7, 2025 |
| SCHUTH ALEXANDER O Chief Operating Officer | Sale at price 20.22 - 20.81 per share. | Direct | 308,291 | Jan 7, 2025 |
| HO CAROLE Officer | Sale at price 20.22 - 20.81 per share. | Direct | 308,291 | Jan 7, 2025 |
| SCHUTH ALEXANDER O Chief Operating Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 3, 2025 |
| HO CAROLE Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 3, 2025 |
| WATTS RYAN J Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 3, 2025 |
| SATO VICKI LEE Director | Sale at price 20.91 per share. | Direct | 64,403 | Jan 2, 2025 |
| KROGNES STEVE E Director | Sale at price 20.25 per share. | Direct | 607,500 | Dec 31, 2024 |
| SCHUTH ALEXANDER O Chief Operating Officer | Conversion of Exercise of derivative security at price 5.28 per share. | Direct | 35,418 | Dec 27, 2024 |
| HO CAROLE Officer | Conversion of Exercise of derivative security at price 0.68 per share. | Direct | 12,135 | Nov 25, 2024 |
| SCHUTH ALEXANDER O Chief Operating Officer | Conversion of Exercise of derivative security at price 0.68 per share. | Direct | 13,951 | Nov 22, 2024 |
| SCHENKEIN DAVID P Director | Conversion of Exercise of derivative security at price 18.00 per share. | Direct | 848,970 | Nov 11, 2024 |
| SCHENKEIN DAVID P Director | Sale at price 32.09 - 32.87 per share. | Direct | 1,932,665 | Nov 11, 2024 |
| SCHUTH ALEXANDER O Officer | Conversion of Exercise of derivative security at price 5.28 per share. | Direct | 82,146 | Nov 7, 2024 |
| SATO VICKI LEE Director | Sale at price 30.00 per share. | Direct | 30,600 | Nov 7, 2024 |
| SCHUTH ALEXANDER O Officer | Sale at price 29.68 - 31.29 per share. | Direct | 465,286 | Nov 7, 2024 |
| SATO VICKI LEE Director | Sale at price 27.07 per share. | Direct | 83,376 | Nov 1, 2024 |
| WATTS RYAN J Chief Executive Officer | Conversion of Exercise of derivative security at price 0.68 per share. | Direct | 27,200 | Oct 18, 2024 |
| WATTS RYAN J Chief Executive Officer | Sale at price 27.69 per share. | Direct | 1,107,600 | Oct 18, 2024 |
| KROGNES STEVE E Director | Sale at price 29.03 per share. | Direct | 870,900 | Sep 30, 2024 |
| SATO VICKI LEE Director | Sale at price 30.00 per share. | Direct | 30,600 | Sep 13, 2024 |
| SATO VICKI LEE Director | Sale at price 24.99 - 25.37 per share. | Direct | 77,007 | Sep 3, 2024 |
| SCHUTH ALEXANDER O Officer | Sale at price 23.54 - 24.78 per share. | Direct | 200,401 | Aug 21, 2024 |
| HO CAROLE Officer | Sale at price 23.79 - 24.96 per share. | Direct | 549,928 | Aug 21, 2024 |
| KROGNES STEVE E Director | Sale at price 23.79 per share. | Direct | 41,085 | Aug 20, 2024 |
| WATTS RYAN J Chief Executive Officer | Sale at price 23.79 per share. | Direct | 53,765 | Aug 20, 2024 |
| SCHUTH ALEXANDER O Chief Operating Officer | Sale at price 22.89 per share. | Direct | 52,006 | Aug 13, 2024 |
| HO CAROLE Officer | Sale at price 22.89 per share. | Direct | 53,494 | Aug 13, 2024 |
| SATO VICKI LEE Director | Sale at price 22.12 - 22.86 per share. | Direct | 68,204 | Jul 1, 2024 |
| KROGNES STEVE E Director | Sale at price 21.79 - 22.80 per share. | Direct | 678,660 | Jul 1, 2024 |
| COOK JENNIFER E Director | Sale at price 21.73 per share. | Direct | 31,682 | Jun 6, 2024 |
| FLATLEY JAY T Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 31, 2024 |
| SATO VICKI LEE Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 31, 2024 |
| TESSIER LAVIGNE MARC T Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 31, 2024 |
| KLEIN PETER S Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 31, 2024 |
| SCHENKEIN DAVID P Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 31, 2024 |
| KROGNES STEVE E Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 31, 2024 |
| COOK JENNIFER E Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 31, 2024 |
| HARRIS ERIK Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 31, 2024 |
| THORNBERRY NANCY A. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 31, 2024 |
| SATO VICKI LEE Director | Sale at price 20.39 per share. | Direct | 34,133 | May 15, 2024 |
| SATO VICKI LEE Director | Sale at price 18.29 per share. | Direct | 30,471 | Apr 15, 2024 |
| KROGNES STEVE E Director | Sale at price 20.50 per share. | Direct | 1,896,250 | Apr 1, 2024 |
| WATTS RYAN J Chief Executive Officer | Stock Gift at price 0.00 per share. | Indirect | 0 | Mar 28, 2024 |
| SATO VICKI LEE Director | Sale at price 20.10 per share. | Direct | 33,487 | Mar 15, 2024 |
| SATO VICKI LEE Director | Sale at price 18.37 per share. | Direct | 30,604 | Feb 15, 2024 |
| SCHUTH ALEXANDER O Chief Operating Officer | Sale at price 17.29 - 17.66 per share. | Direct | 402,420 | Feb 14, 2024 |
| HO CAROLE Officer | Sale at price 17.29 - 17.79 per share. | Direct | 73,130 | Feb 14, 2024 |
| KROGNES STEVE E Director | Sale at price 17.29 per share. | Direct | 47,548 | Feb 13, 2024 |
Related Tickers
BH3.F PTC Therapeutics, Inc.
42.80
+3.38%
HALB Halberd Corporation
0.0024
+33.33%
APRE Aprea Therapeutics, Inc.
1.5300
-0.65%
CYCC Cyclacel Pharmaceuticals, Inc.
0.2225
-1.36%
GNLX Genelux Corporation
3.0300
+3.06%
IMCR Immunocore Holdings plc
30.21
+2.34%
ACET Adicet Bio, Inc.
0.6016
+3.45%
ENZC Enzolytics, Inc.
0.0006
-14.29%
ZYME Zymeworks Inc.
12.41
+2.06%
ACRV Acrivon Therapeutics, Inc.
2.0099
-0.99%